286 related articles for article (PubMed ID: 21643971)
1. The role of RANK/RANKL/OPG signalling pathways in osteoclastogenesis in odontogenic keratocysts, radicular cysts, and ameloblastomas.
Tekkesin MS; Mutlu S; Olgac V
Head Neck Pathol; 2011 Sep; 5(3):248-53. PubMed ID: 21643971
[TBL] [Abstract][Full Text] [Related]
2. Comparative expression of RANK, RANKL, and OPG in keratocystic odontogenic tumors, ameloblastomas, and dentigerous cysts.
da Silva TA; Batista AC; Mendonça EF; Leles CR; Fukada S; Cunha FQ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Mar; 105(3):333-41. PubMed ID: 18061491
[TBL] [Abstract][Full Text] [Related]
3. A Comparison of Ki67, Syndecan-1 (CD138), and Molecular RANK, RANKL, and OPG Triad Expression in Odontogenic Keratocyts, Unicystic Ameloblastoma, and Dentigerous Cysts.
Brito-Mendoza L; Bologna-Molina R; Irigoyen-Camacho ME; Martinez G; Sánchez-Romero C; Mosqueda-Taylor A
Dis Markers; 2018; 2018():7048531. PubMed ID: 30151060
[TBL] [Abstract][Full Text] [Related]
4. Expressions of bax, bcl-2 and Ki-67 in odontogenic keratocysts (Keratocystic Odontogenic Tumor) in comparison with ameloblastomas and radicular cysts.
Soluk Tekkeşın M; Mutlu S; Olgaç V
Turk Patoloji Derg; 2012; 28(1):49-55. PubMed ID: 22207432
[TBL] [Abstract][Full Text] [Related]
5. Expression of parathyroid hormone-related protein (PTHrP), osteoclast differentiation factor (ODF)/receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoclastogenesis inhibitory factor (OCIF)/osteoprotegerin (OPG) in ameloblastomas.
Kumamoto H; Ooya K
J Oral Pathol Med; 2004 Jan; 33(1):46-52. PubMed ID: 14675140
[TBL] [Abstract][Full Text] [Related]
6. Expression and Distribution of Receptor Activator of Nuclear Factor Kappa B, Receptor Activator of Nuclear Factor Kappa B Ligand, and Osteoprotegerin in Periradicular Cysts.
Armada L; Marotta Pdos S; Pires FR; Siqueira JF
J Endod; 2015 Aug; 41(8):1281-7. PubMed ID: 25956608
[TBL] [Abstract][Full Text] [Related]
7. Comparative immunohistochemical expression of RANK, RANKL and OPG in radicular and dentigerous cysts.
de Moraes M; de Lucena HF; de Azevedo PR; Queiroz LM; Costa Ade L
Arch Oral Biol; 2011 Nov; 56(11):1256-63. PubMed ID: 21683340
[TBL] [Abstract][Full Text] [Related]
8. Identification of RANKL in osteolytic lesions of the facial skeleton.
Tay JY; Bay BH; Yeo JF; Harris M; Meghji S; Dheen ST
J Dent Res; 2004 Apr; 83(4):349-53. PubMed ID: 15044512
[TBL] [Abstract][Full Text] [Related]
9. Immunoexpression of RANK, RANKL and OPG in sporadic odontogenic keratocysts and their potential association with recurrence.
Kisielowski K; Drozdzowska B; Koszowski R; Rynkiewicz M; Szuta M; Rahnama M; Babiuch K; Tyrakowski M; Bednarczyk A; Kaczmarzyk T
Adv Clin Exp Med; 2021 Mar; 30(3):301-307. PubMed ID: 33768738
[TBL] [Abstract][Full Text] [Related]
10. The immunoprofile of odontogenic keratocyst (keratocystic odontogenic tumor) that includes expression of PTCH, SMO, GLI-1 and bcl-2 is similar to ameloblastoma but different from odontogenic cysts.
Vered M; Peleg O; Taicher S; Buchner A
J Oral Pathol Med; 2009 Aug; 38(7):597-604. PubMed ID: 19473442
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of receptor activator nuclear κB ligand and osteoprotegerin in odontogenic cysts and tumors.
de Matos FR; de Moraes M; das Neves Silva EB; Galvão HC; de Almeida Freitas R
J Oral Maxillofac Surg; 2013 Nov; 71(11):1886-92. PubMed ID: 23992784
[TBL] [Abstract][Full Text] [Related]
12. Differentiated Immunohistochemical Expression of Osteoclastogenic Markers in Radicular Cyst, Odontogenic Keratocyst, and Ameloblastoma.
Capella DL; Embaló B; Vieira DSC; Gondak RO; Rivero ERC
Appl Immunohistochem Mol Morphol; 2021 May-Jun 01; 29(5):352-358. PubMed ID: 33944809
[TBL] [Abstract][Full Text] [Related]
13. Activation of the Akt/mTOR pathway in dentigerous cysts, odontogenic keratocysts, and ameloblastomas.
Chaisuparat R; Yodsanga S; Montaner S; Jham BC
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Sep; 116(3):336-42. PubMed ID: 23953418
[TBL] [Abstract][Full Text] [Related]
14. Effect of technetium-99 conjugated with methylene diphosphonate (
Shen S; Wang W; Yang C; Xu B; Zeng L; Qian Y
J Oral Pathol Med; 2019 Feb; 48(2):129-135. PubMed ID: 30421571
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of bone remodeling molecules expression in different types of jaw ameloblastoma.
Iakovou M; Chrysomali E; Piperi E; Fanourakis G; Sklavounou A; Vlachodimitropoulos D; Tseleni-Balafouta S
J Oral Pathol Med; 2015 Aug; 44(7):543-51. PubMed ID: 25243582
[TBL] [Abstract][Full Text] [Related]
16. RANK, RANKL, and OPG in recurrent solid/multicystic ameloblastoma: their distribution patterns and biologic significance.
Siar CH; Tsujigiwa H; Ishak I; Hussin NM; Nagatsuka H; Ng KH
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jan; 119(1):83-91. PubMed ID: 25446507
[TBL] [Abstract][Full Text] [Related]
17. Caveolin-1 expression in odontogenic cysts and ameloblastomas.
Jaafari-Ashkavandi Z; Pardis S; Asadzadeh M; Andisheh-Tadbir A; Dehghani-Nazhvani A
Turk Patoloji Derg; 2014; 30(2):94-9. PubMed ID: 24782297
[TBL] [Abstract][Full Text] [Related]
18. Expression of bone resorption regulators (RANK, RANKL, and OPG) in odontogenic tumors.
Andrade FR; Sousa DP; Mendonça EF; Silva TA; Lara VS; Batista AC
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Oct; 106(4):548-55. PubMed ID: 18928898
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of bone resorption regulators (RANKL and OPG), angiogenic index, and myofibroblasts in syndrome and non-syndrome odontogenic keratocysts.
Nonaka CF; Cavalcante RB; Nogueira RL; de Souza LB; Pinto LP
Arch Oral Biol; 2012 Mar; 57(3):230-7. PubMed ID: 21871606
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of nicotinamide N-methyltransferase in primary and recurrent ameloblastomas and odontogenic keratocysts.
Mascitti M; Sartini D; Togni L; Pozzi V; Rubini C; Santarelli A; Emanuelli M
Eur J Clin Invest; 2020 Apr; 50(4):e13220. PubMed ID: 32129473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
